奥精医疗
(688613)
| 流通市值：25.48亿 | | | 总市值：25.48亿 |
| 流通股本：1.37亿 | | | 总股本：1.37亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 103,297,645.37 | 169,066,830.02 | 137,942,858.62 | 147,420,309.82 |
| 交易性金融资产 | 916,742,908.16 | 913,628,841.45 | 910,442,208.2 | 909,481,433.71 |
| 应收票据及应收账款 | 38,090,405.56 | 27,461,113.17 | 57,562,253.96 | 51,755,014.28 |
| 应收账款 | 38,090,405.56 | 27,461,113.17 | 57,562,253.96 | 51,755,014.28 |
| 预付款项 | 7,482,438.03 | 17,137,541.12 | 5,653,921.75 | 5,018,606.74 |
| 其他应收款合计 | 14,458,892.89 | 11,503,042.1 | 13,871,658.99 | 12,145,521.55 |
| 存货 | 79,743,097.95 | 76,942,451.94 | 85,598,891.55 | 96,435,870.5 |
| 其他流动资产 | 8,080,498.43 | 7,798,177.91 | 3,973,651.06 | 5,666,039.49 |
| 流动资产合计 | 1,167,895,886.39 | 1,223,537,997.71 | 1,215,045,444.13 | 1,227,922,796.09 |
| 非流动资产: | | | | |
| 投资性房地产 | 48,944,920.52 | 49,684,150.67 | 50,423,380.82 | 51,162,610.97 |
| 固定资产 | 164,345,327.09 | 163,357,732.44 | 165,074,044.98 | 168,060,456.47 |
| 在建工程 | 7,365,757.41 | 7,354,436.66 | 3,352,134.43 | - |
| 使用权资产 | 6,634,399.16 | 7,331,779.58 | 2,156,625.62 | 3,826,656.45 |
| 无形资产 | 23,278,636.71 | 23,759,840.26 | 23,976,643.71 | 24,482,249.31 |
| 商誉 | 24,618,560.01 | 24,618,560.01 | 24,618,560.01 | 24,618,560.01 |
| 长期待摊费用 | 28,867,633.78 | 30,493,809.72 | 29,642,059.6 | 33,193,658.18 |
| 递延所得税资产 | 23,425,928.71 | 23,425,928.71 | 23,838,789.91 | 23,838,789.91 |
| 其他非流动资产 | 9,592,778.23 | 10,319,166.55 | 6,708,401.93 | 3,816,752.94 |
| 非流动资产合计 | 337,073,941.62 | 340,345,404.6 | 329,790,641.01 | 332,999,734.24 |
| 资产总计 | 1,504,969,828.01 | 1,563,883,402.31 | 1,544,836,085.14 | 1,560,922,530.33 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 4,754,201.66 | 12,406,269.91 | 15,634,884.31 | 25,154,172.69 |
| 应付账款 | 4,754,201.66 | 12,406,269.91 | 15,634,884.31 | 25,154,172.69 |
| 合同负债 | 4,308,393.75 | 5,656,771.43 | 5,560,126.41 | 6,042,252.57 |
| 应付职工薪酬 | 5,254,251.35 | 18,559,291.79 | 4,611,273.72 | 4,909,427.07 |
| 应交税费 | 2,838,007.75 | 5,947,305.64 | 3,592,631.13 | 3,588,770.66 |
| 其他应付款合计 | 901,795.37 | 1,777,384.28 | 1,922,504.48 | 8,599,326.21 |
| 一年内到期的非流动负债 | 3,339,831.63 | 36,898,239.35 | 35,899,831.63 | 36,613,504.77 |
| 其他流动负债 | 558,587.37 | 735,064.53 | 722,816.43 | 785,492.83 |
| 流动负债合计 | 21,955,068.88 | 81,980,326.93 | 67,944,068.11 | 85,692,946.8 |
| 非流动负债: | | | | |
| 长期借款 | 5,200,000 | 6,500,000 | 6,500,000 | 7,800,000 |
| 租赁负债 | 6,624,967.3 | 4,534,845.31 | 844,828.33 | 2,190,852.15 |
| 递延收益 | 20,171,264.25 | 19,971,264.25 | 20,476,383.75 | 20,941,503.25 |
| 递延所得税负债 | 3,531,003.56 | 3,538,361.29 | 293,395.52 | 295,764.48 |
| 非流动负债合计 | 35,527,235.11 | 34,544,470.85 | 28,114,607.6 | 31,228,119.88 |
| 负债合计 | 57,482,303.99 | 116,524,797.78 | 96,058,675.71 | 116,921,066.68 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 137,008,584 | 137,008,584 | 137,008,584 | 137,008,584 |
| 资本公积 | 982,581,561.42 | 982,581,561.42 | 982,581,561.42 | 982,581,561.42 |
| 其他综合收益 | -238,624.48 | 151,061.83 | 476,453.29 | 759,921.98 |
| 盈余公积 | 50,767,924.77 | 50,767,924.77 | 46,886,146.23 | 46,886,146.23 |
| 未分配利润 | 265,508,596.16 | 264,097,621.52 | 268,080,770.49 | 262,115,499.6 |
| 归属于母公司股东权益合计 | 1,435,628,041.87 | 1,434,606,753.54 | 1,435,033,515.43 | 1,429,351,713.23 |
| 少数股东权益 | 11,859,482.15 | 12,751,850.99 | 13,743,894 | 14,649,750.42 |
| 股东权益合计 | 1,447,487,524.02 | 1,447,358,604.53 | 1,448,777,409.43 | 1,444,001,463.65 |
| 负债和股东权益合计 | 1,504,969,828.01 | 1,563,883,402.31 | 1,544,836,085.14 | 1,560,922,530.33 |
| 公告日期 | 2026-04-29 | 2026-04-29 | 2025-10-30 | 2025-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |